ECE2008 Poster Presentations Adrenal (61 abstracts)
Free fatty acids affect urinary excretion of androgen precursors thereby linking metabolism and hyperandrogenemia in vivo: results of a randomized, controlled trial
Knut Mai 1 , Thomas Bobbert 1 , Franziska Reinecke 1 , Janin Andres 1 , Volker Bähr 1 , Christiane Maser-Gluth 4 , Stefan Wudy 5 , Michaela Hartmann 5 , Matthias Möhlig 1 , Martin O Weickert 2 , Heinrich Schulte 3 , Sven Diederich 3 , Andreas Pfeiffer 1 & Joachim Spranger 1
1Department of Endocrinology, Diabetes and Nutrition, Charite – University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany; 2Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany; 3Endokrinologikum Berlin, Berlin, Germany; 4Steroid Laboratory, Department of Pharmacology, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany; 5Steroid Research Unit, Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany.
Context: The polycystic ovarian syndrome (PCOS) is characterized by hyperandrogenism and associated with obesity and impaired glucose metabolism. Despite the high prevalence of PCOS and the considerable clinical impact, the precise interplay between metabolism and hyperandrogenemia is not entirely clear. We therefore aimed to analyse the relation between circulating free fatty acids (FFAs) and androgen metabolism in vivo in women.
Design and participants: Twelve healthy young women during the early follicular phase of two subsequent cycles were investigated. A randomized controlled cross-over trial was performed. Following a 10-h overnight fast, 20% lipid/heparin or saline/heparin infusion was administered at a rate of 1.5 ml/min for 5 h.
Main outcome measures: Circulating androgens and their precursors as well as 24 h-urinary excretion of free DHEA, DHEAS, androstenedione, androsterone (An), etiocholanolone (Et), 5-androstene-3β,17α-diol, 5-androstene-3β,17β-diol, DHEA, 16α-hydroxy-DHEA, and 5-androstene-3β,16α,17β-triol) were measured.
Results: FFAs induced elevated circulating levels of androstenedione, DHEA, DHEAS, testosterone, DHT, estrone and 17β-estradiol. Urinary excretion of DHEA, free DHEAS, 5-androstene-3β,17α-diol and sum of urinary excreted DHEA and its 16-hydroxylated downstream metabolites 16α-hydroxy-DHEA and 5-androstene-3β,16α,17β-triol were reduced by FFAs.
Conclusions: Elevation of FFAs increases adrenal androgen precursors DHEA and DHEAS by lowering their urinary excretion in vivo in healthy young women. The here described mechanism might contribute to the development of hyperandrogenism in women with PCOS and suggests novel therapeutic targets to treat those patients.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more